Publications by authors named "Isamu Otuka"
Anticancer Res
October 2022
Article Synopsis
- Radium-223 therapy shows better survival outcomes when given before docetaxel rather than after in patients with advanced prostate cancer.
- In a study of 36 patients, those receiving Ra-223 prior to docetaxel had higher treatment completion rates and longer progression-free and cause-specific survival.
- The safety profile was also more favorable for the pre-docetaxel group, with lower rates of serious adverse events, indicating that timing of treatment could significantly impact patient outcomes.
